Literature DB >> 24867963

Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation.

Nita R Shah1, Robert E W Hancock1, Rachel C Fernandez2.   

Abstract

Bordetella pertussis, the causative agent of whooping cough, has many strategies for evading the human immune system. Lipopolysaccharide (LPS) is an important Gram-negative bacterial surface structure that activates the immune system via Toll-like receptor 4 and enables susceptibility to cationic antimicrobial peptides (CAMPs). We show modification of the lipid A region of LPS with glucosamine increased resistance to numerous CAMPs, including LL-37. Furthermore, we demonstrate that this glucosamine modification increased resistance to outer membrane perturbation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867963      PMCID: PMC4136009          DOI: 10.1128/AAC.02590-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Antimicrobial peptides in the airway.

Authors:  D M Laube; S Yim; L K Ryan; K O Kisich; G Diamond
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.

Authors:  R C Fernandez; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 3.  Pertussis: a matter of immune modulation.

Authors:  Daan de Gouw; Dimitri A Diavatopoulos; Hester J Bootsma; Peter W M Hermans; Frits R Mooi
Journal:  FEMS Microbiol Rev       Date:  2011-01-05       Impact factor: 16.408

4.  The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation.

Authors:  Shaan L Gellatly; Brittany Needham; Laurence Madera; M Stephen Trent; Robert E W Hancock
Journal:  Infect Immun       Date:  2012-06-18       Impact factor: 3.441

5.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

Authors:  Irith Wiegand; Kai Hilpert; Robert E W Hancock
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

7.  Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog.

Authors:  Nico Marr; Alina Tirsoaga; Didier Blanot; Rachel Fernandez; Martine Caroff
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

8.  The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Sam Attah-Poku; Hugh G G Townsend; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.

Authors:  Olivier Rolin; Sarah J Muse; Chetan Safi; Shokrollah Elahi; Volker Gerdts; Lauren E Hittle; Robert K Ernst; Eric T Harvill; Andrew Preston
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

10.  Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation.

Authors:  Nita R Shah; Sami Albitar-Nehme; Emma Kim; Nico Marr; Alexey Novikov; Martine Caroff; Rachel C Fernandez
Journal:  J Biol Chem       Date:  2013-03-06       Impact factor: 5.157

View more
  18 in total

Review 1.  Bacterial strategies of resistance to antimicrobial peptides.

Authors:  Hwang-Soo Joo; Chih-Iung Fu; Michael Otto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

Review 2.  Antimicrobial peptide resistance in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; David S Stephens
Journal:  Biochim Biophys Acta       Date:  2015-05-19

3.  Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors:  Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

4.  Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A.

Authors:  Jesús Arenas; Elder Pupo; Eline de Jonge; Jesús Pérez-Ortega; Joerg Schaarschmidt; Peter van der Ley; Jan Tommassen
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

Review 5.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  Top-Down Characterization of Lipooligosaccharides from Antibiotic-Resistant Bacteria.

Authors:  Dustin R Klein; Matthew J Powers; M Stephen Trent; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2019-07-26       Impact factor: 6.986

7.  Antimicrobial Peptide Resistance Genes in the Plant Pathogen Dickeya dadantii.

Authors:  Caroline Pandin; Martine Caroff; Guy Condemine
Journal:  Appl Environ Microbiol       Date:  2016-10-14       Impact factor: 4.792

Review 8.  Antibiofilm activity of host defence peptides: complexity provides opportunities.

Authors:  Morgan A Alford; Evan F Haney; Robert E W Hancock
Journal:  Nat Rev Microbiol       Date:  2021-06-28       Impact factor: 60.633

9.  Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants.

Authors:  Jesús Pérez-Ortega; Roel M Van Harten; Ria Van Boxtel; Michel Plisnier; Marc Louckx; Dominique Ingels; Henk P Haagsman; Jan Tommassen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 10.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.